Why is Malaysia starting the third phase Covid-19 vaccine trial soon?

Question

Accepted Answer

Malaysia Commences Final-Stage Covid-19 Vaccine Trials to Assess Population Suitability

Malaysia is set to initiate the third phase of clinical trials for a Covid-19 vaccine candidate, a crucial step aimed at ensuring its safety and efficacy within the local population. This decision follows promising outcomes from earlier trial stages conducted internationally. The trial will focus on an inactivated virus vaccine developed by the Institute of Medical Biology, Chinese Academy of Medical Sciences in Beijing.
Assessment of Safety and Efficacy in Malaysians

The primary impetus for conducting the Phase 3 trial in Malaysia is to ascertain the vaccine's suitability for the nation's demographic. While initial Phase 1 and Phase 2 trials have indicated that the vaccine is safe and has yielded positive results, these were likely conducted in different populations. Therefore, this extensive trial is designed to specifically evaluate how the vaccine performs in terms of safety and its ability to generate an immune response among Malaysian participants.
Rigorous Trial Design and Oversight

The upcoming trial has been officially registered with the National Medical Research Registry, underscoring its adherence to established research protocols. A principal investigator appointed by the Ministry of Health will lead the study, with support from a local clinical research organisation. The trial is planned to take place across eight designated centres, including major hospitals such as Ampang Hospital, Sarawak General Hospital, and Penang Hospital, ensuring broad geographical representation and accessibility for participants.
Projected Participant Numbers and Timeline

The comprehensive nature of the trial is reflected in its projected scale, with an anticipated 3,000 participants to be enrolled. This significant number is expected to provide robust data for statistical analysis. The Medical Research and Ethics Committee is scheduled to review the trial proposal on December 10, with the aim of commencing the study by the end of December or early in the new year, pending regulatory approval.

Reading history

Hide →

This history is cleared when the page is closed.

Why is Malaysia starting the third phase Covid-19 vaccine trial soon?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends